Clinical Trial Update: FHND1002 for ALS Treatment: Phase 2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for FHND1002 in amyotrophic lateral sclerosis, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• FHND1002

Snippet

Sponsor: Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: NOT_YET_RECRUITING